These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 18620951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Management of Paget's disease of bone.
    Langston AL, Ralston SH.
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of Paget's disease of bone.
    Ralston SH.
    Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
    [Abstract] [Full Text] [Related]

  • 4. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A.
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    Phillips J, Subedi D, Lewis SC, Keerie C, Ralston SH.
    ; 2024 06. PubMed ID: 38950131
    [Abstract] [Full Text] [Related]

  • 8. Paget's disease of bone: clinical, pathogenetic and therapeutic aspects.
    Papapoulos SE.
    Baillieres Clin Endocrinol Metab; 1997 Apr; 11(1):117-43. PubMed ID: 9222489
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Paget's disease: case report].
    Wegierska M, Ignaczak P, Zalewska J, Jeka S.
    Ann Acad Med Stetin; 2011 Apr; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [Abstract] [Full Text] [Related]

  • 13. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA, Altayar O, BenKhadra K, Qasim Agha OQ, Asi N, Nabhan M, Prokop LJ, Tebben P, Murad MH.
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [Abstract] [Full Text] [Related]

  • 14. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Jul; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 15. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM, Au-Yeong ML, McKenna MJ.
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
    Pirih FQ, Zablotsky M, Cordell K, McCauley LK.
    J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of Paget's disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS).
    Rendina D, Falchetti A, Diacinti D, Bertoldo F, Merlotti D, Giannini S, Cianferotti L, Girasole G, Di Monaco M, Gonnelli S, Malavolta N, Minisola S, Vescini F, Rossini M, Frediani B, Chiodini I, Asciutti F, Gennari L.
    J Endocrinol Invest; 2024 Jun; 47(6):1335-1360. PubMed ID: 38488978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.